Stay updated on LAG-3 in GBM: Alone & with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page.

Latest updates to the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page
- Check5 days agoChange DetectedA new Nat Med 2026 publication entry by Lim et al. is added with full citation details, and the prior 'Online ahead of print' citation is removed.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, representing an internal version update.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page's revision tag updated from v3.6.3 to v3.6.4, indicating a minor release or maintenance update. No study content or data appear to be changed.SummaryDifference0.0%

- Check34 days agoChange DetectedPublications section added to the study record. It includes a PubMed-sourced citation for 'Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial' and a note that publications are automatically filled from PubMed.SummaryDifference0.2%

- Check48 days agoChange Detected- The page revision label was updated from v3.6.2 to v3.6.3, indicating a new revision of the page content. This reflects a minor metadata update and does not alter the study details displayed.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, signaling a small editorial or formatting update without changing the underlying information.SummaryDifference0.0%

Stay in the know with updates to LAG-3 in GBM: Alone & with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page.